Journals / Anadolu Kardiyoloji Dergisi / 2005 / Cilt: 5 - Sayı: 1

Is slow coronary flow related with inflammation and procoagulant state

Koroner yavaş akım inflamasyonla ve prokoagülan durumla ilişkili midir?

Pages
3–7
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings on normal levels of CRP and procoagulant activity, and lack of relation with TIMI frame count made us to think that inflammatory and procoagulant activity did not play a role in the pathogenesis of CSF.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the pathogenesis of coronary slow flow (CSF), C-reactive protein (CRP) levels as indicator of inflammation and procoagulant activity were studied in patients with CSF.
📊
Key Findings & Data:Methods: Fifty-one patients (22 female, mean age; 53±10 years) who were admitted to our clinic with chest pain and had the diagnosis of CSF established by TIMI frame count method and coronary angiography, and 44 healthy subjects (18 female, mean age; 54±6 years) with normal coronary flow (NCF) were included in the study.
💡
Conclusion & Impact:Conclusion: Our findings on normal levels of CRP and procoagulant activity, and lack of relation with TIMI frame count made us to think that inflammatory and procoagulant activity did not play a role in the pathogenesis of CSF.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the pathogenesis of coronary slow flow (CSF), C-reactive protein (CRP) levels as indicator of inflammation and procoagulant activity were studied in patients with CSF. Methods: Fifty-one patients (22 female, mean age; 53±10 years) who were admitted to our clinic with chest pain and had the diagnosis of CSF established by TIMI frame count method and coronary angiography, and 44 healthy subjects (18 female, mean age; 54±6 years) with normal coronary flow (NCF) were included in the study. Subjects with any infectious and systemic immune disease were excluded from the study. The CRP levels were measured from venous blood samples during admission, at 24th hour and after 3 months in all subjects. Additionally; fibrinogen, plasminogen, plasminogen activator inhibitor (PAI-1), tissue plasminogen activator (t-PA) and von Willebrand factor (vWF) levels were measured to determine the procoagulant activity. Results: There was no significant difference between CRP levels of patients with CSF and healthy subjects during admission (7.26±4.2 ng/dl vs. 6.43±2.8 ng/dl, p>0.05), at 24th hour (7.84±1.3 ng/dl vs. 6.32±2.5 ng/dl, p>0.05) and after 3 months (6.37+2.4 ng/dl vs. 6.18±3.3 ng/dl, p>0.05). There were no differences between levels of CRP when compared according to the TIMI frame count, number of vessels with CSF and artery in which CSF was dominant. Additionally; procoagulant activity assessed by fibrinogen, plasminogen, PAI-1, t-PA and vWF levels was similar in both groups. Conclusion: Our findings on normal levels of CRP and procoagulant activity, and lack of relation with TIMI frame count made us to think that inflammatory and procoagulant activity did not play a role in the pathogenesis of CSF.

Özet

Amaç: Bu çalışmada, koroner yavaş akım (KYA) patogenezini araştırmaya yönelik olarak, hastalarda, inflamasyonun biyokimyasal göstergelerinden C-reaktif protein (CRP) düzeyleri ve prokoagülan aktivite araştırılmıştır. Yöntemler: Çalışmaya, kliniğimize göğüs ağrısı ile başvuran ve koroner anjiyografi ve TİMİ kare sayısı yöntemi ile KYA tanısı konulan 51 has-ta (22'si kadın, yaş ortalaması; 53±10 yıl) ve normal koroner akımı (NKA) olan 44 sağlıklı olgu (18'i kadın, yaş ortalaması; 54±6 yıl) alındı. Herhangi bir infeksiyöz veya sistemik immün hastalığı olanlar çalışmadan dışlandı. Tüm olguların başvuru sırasında, 24. saatte ve üç ay sonraki venöz kan örneklerinden CRP düzeyleri ölçüldü: Ek olarak, prokoagülan aktiviteyi belirlemek için tüm olguların fibrinojen, plazminojen, plazminojen aktivatör inhibitör-1 (PAI-1), doku plazminojen aktivatörü (t-PA) ve von Willebrand faktör a (vWF) düzeyleri değerlendirildi. Bulgular: Koroner yavaş akım ve NKA olan olguların, başvuru sırasında; (7.26±4.2 ng/dl'e karşın 6.43±2.8 ng/dl, p>0.05), 24 saat sonra; (7.84±1.3 ng/dl'e karşın 6.32±2.5 ng/dl, p>0.05) ve üç ay sonraki; (6.37+2.4 ng/dl'e karşın 6.18+3.3 ng/dl, p>0.05) CRP düzeyleri arasında fark yoktu. TİMİ kare sayısına göre, KYA olan damar sayısı ve KYA'ın dominant olduğu artere göre karşılaştırma yapıldığında da CRP düzeyleri arasında fark olmadığı saptandı. Ek olarak, her iki grup arasında fibrinojen, plazminojen, PAI-1, t-PA ve vWF düzeyleri ile değerlendirilen prokoagülan aktivite benzerlik gösteriyordu. Sonuç: Bu çalışmada, CRP düzeylerinin ve prokoagülan aktivitenin normal sınırlarda ve TİMİ kare sayısı ile ilişkisiz bulunması, KYA'ın patogenezinde inflamatuvar ve prokoagülan aktivitenin NKA'lı bireylerden farklılık göstermediğini düşündürmektedir.

🔖

Cite This Article

AKSAKAL, E., SAĞKAN, O., YAZICI, M., ŞAHİN, M., DEMİRCAN, S. (2022). Is slow coronary flow related with inflammation and procoagulant state. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 1, 3–7. https://ajindex.com/articles/437379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Van Lierde J, Vrolix M, Sionis D, De Geest H, Piessens J. Lack of evidence for small vessel disease in a patient with “slow dye progression” in the coronary arteries. Cathet Cardiovasc Diagn 1991
  2. Cesar LA, Ramires JA, Serrano Junior CV, et al. Slow coronary run-off in patients with angina pectoris: clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res 1996
  3. Tambe AA, Demany MA, Zimmerman HA, Masearanhas E. Angina pectoris and slow flow velocity of dye in coronary arteries, a new angiographic finding.Am Heart J 1972
  4. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count. A quantitative method of assessing coronary artery flow. Circulation 1996
  5. Goel PK, Gupta SK, Aggarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in Syndrome X. Angiology 2001
  6. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986
  7. Vrints C, Herman AG. Role of the endothelium in the regulation of coronary artery tone. Acta Cardiol 1991
  8. Cannon RO 3rd, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988
  9. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986
  10. Cermak J, Key NS, Bach RR, Balla J, Jacop HS, Vercelotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993
  11. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology 2002
  12. Yazıcı M, Demircan S, Aksakal E, et al. Yavaş koroner akımlı hastalarda plazma insülin, glukoz, lipid düzeyleri ve düzeltilmiş TIMI kare sayısı ile ilişkisi. Anadolu Kardiyol Derg 2003
  13. Chambers J, Bass C. Chest pain with normal coronary anatomy: a review of natural history and possible etiologic factors. Prog Cardiovasc Dis 1990: 33: 161-84. 14. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995: 25: 807-14. 15. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and a